Pza Resistance | List of Frontiers open access articles

Original Research

Published on 08 Jan 2025

Phenotypic and genotypic characterization of Mycobacterium tuberculosis pyrazinamide resistance—India, 2018–2020

in Antimicrobials, Resistance and Chemotherapy

Sembulingam Tamilzhalagan
Evanslin Santus Justin
Ashok Selvaraj
Karthick Venkateswaran
Arun Kumar Sivakumar
Suganthi Chittibabu
Heather P. McLaughlin
Patrick K. Moonan
Jonathan P. Smith
Sakthi Suba

Frontiers in Microbiology

doi 10.3389/fmicb.2024.1515627

4,099 views
2 citations

Original Research

Published on 23 Jul 2021

Structural and Genomic Insights Into Pyrazinamide Resistance in Mycobacterium tuberculosis Underlie Differences Between Ancient and Modern Lineages

in Biological Modeling and Simulation

Tanushree Tunstall
Jody Phelan
Charlotte Eccleston
Taane G. Clark
Nicholas Furnham

Frontiers in Molecular Biosciences

doi 10.3389/fmolb.2021.619403

4,803 views
10 citations

Original Research

Published on 19 Feb 2019

Mutations in Efflux Pump Rv1258c (Tap) Cause Resistance to Pyrazinamide, Isoniazid, and Streptomycin in M. tuberculosis

in Antimicrobials, Resistance and Chemotherapy

Jiayun Liu
Wanliang Shi
Shuo Zhang
Xiaoke Hao
Dmitry A. Maslov
Kirill V. Shur
Olga B. Bekker
Valery N. Danilenko
Ying Zhang

Frontiers in Microbiology

doi 10.3389/fmicb.2019.00216

11,004 views
65 citations

Original Research

Published on 21 Oct 2025

Determining the minimum inhibitory concentrations of pyrazinamide against Mycobacterium tuberculosis clinical isolates at a neutral pH of 6.8 using the broth microdilution method

in Infectious Agents and Disease

Maria Tamblin
Wanliang Shi
Liang Chen
Jessica Reynolds

Frontiers in Microbiology

doi 10.3389/fmicb.2025.1688772

2,774 views

Original Research

Published on 11 Jan 2021

Characterization of pncA Mutations and Prediction of PZA Resistance in Mycobacterium tuberculosis Clinical Isolates From Chongqing, China

in Antimicrobials, Resistance and Chemotherapy

Kun Li
Zhongping Yang
Jing Gu
Ming Luo
Jiaoyu Deng
Yaokai Chen

Frontiers in Microbiology

doi 10.3389/fmicb.2020.594171

8,722 views
22 citations

Original Research

Published on 10 Dec 2019

Structural Dynamics Behind Clinical Mutants of PncA-Asp12Ala, Pro54Leu, and His57Pro of Mycobacterium tuberculosis Associated With Pyrazinamide Resistance

in Computational Genomics

Aamir Mehmood
Muhammad Tahir Khan
Aman Chandra Kaushik
Anwar Sheed Khan
Muhammad Irfan
Dong-Qing Wei

Frontiers in Bioengineering and Biotechnology

doi 10.3389/fbioe.2019.00404

4,735 views
33 citations

Hypothesis and Theory

Published on 24 Feb 2015

Drug-resistant tuberculosis can be predicted by Mycobacterial interspersed repetitive unit locus

in Antimicrobials, Resistance and Chemotherapy

Wen Yu-feng
Jiang Chao
Cheng Xian-feng

Frontiers in Microbiology

doi 10.3389/fmicb.2015.00147

5,864 views
5 citations

Articles

Phenotypic and genotypic characterization of Mycobacterium tuberculosis pyrazinamide resistance—India, 2018–2020

Structural and Genomic Insights Into Pyrazinamide Resistance in Mycobacterium tuberculosis Underlie Differences Between Ancient and Modern Lineages

Mutations in Efflux Pump Rv1258c (Tap) Cause Resistance to Pyrazinamide, Isoniazid, and Streptomycin in M. tuberculosis

Determining the minimum inhibitory concentrations of pyrazinamide against Mycobacterium tuberculosis clinical isolates at a neutral pH of 6.8 using the broth microdilution method

Characterization of pncA Mutations and Prediction of PZA Resistance in Mycobacterium tuberculosis Clinical Isolates From Chongqing, China

Structural Dynamics Behind Clinical Mutants of PncA-Asp12Ala, Pro54Leu, and His57Pro of Mycobacterium tuberculosis Associated With Pyrazinamide Resistance

Drug-resistant tuberculosis can be predicted by Mycobacterial interspersed repetitive unit locus